2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock
The Motley Fool
Ginkgo Bioworks is facing significant risks, including deteriorating operating efficiency and potential loss of customers, but also has opportunities to become a preferred R&D or manufacturing collaborator in biopharma and a preferred biosecurity services provider. The company's future profitability remains uncertain, and investors should closely monitor its earnings in the coming years.
Continue Reading